Asthma metabolomics uncovered biologically distinct disease subtypes in clinically stable patients. Learn more about the ...

Please provide your email address to receive an email when new articles are posted on . Among children with eosinophilic asthma receiving mepolizumab who had an exacerbation during an acute ...

A new study led by researchers at the Yale Center for Asthma and Airways Disease and the Center for Pulmonary Precision Medicine (P2MED) in the Yale Section of Pulmonary, Critical Care and Sleep ...

Dupilumab (interleukin-4Rα; antibody binds to interleukin-4Rα, inhibiting interleukin-4 and interleukin-13 signaling in hematopoietic cells [e.g., B cells, CD4+ helper T cells, and eosinophils], ...

A randomized clinical trial with 1879 children 6 months to 12 years old with asthma exacerbation and fever, showing a lower incidence of outpatient visits for asthma in those randomly assigned to ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Patients who received biologic treatment for asthma did ...

Xolair, an antibody asthma drug, was recently approved for severe food allergic reactions. It is not the first biological drug to treat multiple conditions. But it is the first to treat severe food ...

For hundreds of years, people have observed that asthma severity often worsens in the nighttime. One longstanding question has been to what degree the body's internal circadian clock - as opposed to ...

People with asthma face substantial out-of-pocket costs-even when they take medications to manage their illness. However, many choose to continue treatment despite these costs. We used the 2003-2009 ...

Asthma can be predicted using non-biological measurements from the age of 3 years, according to one study. Machine learning models can predict physician-diagnosed asthma in early childhood, a recent ...